Belcher Pharmaceuticals, LLC

Facts at a Glance

U.S. brand pharmaceutical manufacturer sales for 2007: $228 billion.
U.S. generic pharmaceutical manufacturer sales: $58.5 billion. (source: IMS National Sales Perspective, Moving Annual Total, Nov. 2007)
The top five U.S. corporations by unbranded generic prescriptions dispensed are Teva Pharmaceuticals USA, Mylan Inc., Sandoz (Novartis), Watson Pharmaceuticals, and Mallinckrodt, respectively.
10,072 of the 12,751 drugs listed in the FDA's Orange Book have generic counterparts. (source: FDA, MedAd News)

Generic medicines account for 69% of all prescriptions dispensed in the United States, yet only 16% of all dollars spent on prescriptions. (source: IMS Health)
Generic pharmaceutical products are used to fill nearly 2.6 billion prescriptions every year.
In 2008, the top 10 generic drugs, by prescriptions dispensed in the United States, were HYCD/APAP, Levothyroxine, Amoxicillin, Lisinopril, Simvastatin, hydrochlorothiazid, amlodipine besy, azithromycin, warfarin sodium, furosemide. (source: IMS Health, National Prescription Audit, Dec. 2008)

In 2007, the average retail price of a generic prescription drug was $34.34. The average retail price of a brand name prescription drug was $119.51. (source: The National Association of Chain Drug Stores, 2007)
According to a 1998 study by the Congressional Budget Office, generic drugs save consumers between $8 billion and $10 billion each year.

The generic industry is growing at more than 7.8%, a pace that is faster than the world pharmaceutical market. (source: IMS Health)
Blockbuster products expected to come off patent in 2009 include Flomox, AmbienCR, Arimidex, Cellcept, Keppra, Imigran, Prevacid, Topamax, Valtrex. (source: IMS Health)